Sign in
VOQP Stock Price, Chart, Stats & News
VioQuest Pharmaceuticals, Inc.
Save
VioQuest Pharmaceuticals, Inc. (VOQP) does not currently pay a dividend.
14,719
Market cap
–
Current P/E
–
Forward P/E
VOQP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
VioQuest Pharmaceuticals, Inc. is a biopharmaceutical entity that concentrates on obtaining, developing, and marketing drug therapies in clinical stages, specifically targeting oncology and infectious diseases. Its primary product, Xyfid, is currently being advanced for both the management and prevention of hand-foot syndrome. The company's pipeline also features VQD-002, a nucleoside analog presently in Phase I clinical trials for cancer treatment.
Similar securities
Based on sector and market capitalization
Report issue